Table 4 Life expectancy, AF prevalence and stroke incidence in the overall population and in the simulated cohort
| Â | Life expectancy years (simulated cohort) | AF prevalence (%) (total population) | AF prevalence (%) (simulated cohort) | Yield of screening (previously undetected AF) * | Stroke incidence (per 1000) (total population) | Stroke incidence (per 1000) (simulated cohort) |
|---|---|---|---|---|---|---|
Switzerland | 14.7 | 1.5% | 6.7% | 2.23% | 2.01 | 7.0 |
UK | 13.6 | 2.3% | 10.2% | 3.40% | 1.76 | 5.5 |
Greece | 13.7 | 2.2% | 8.0% | 2.67% | 2.77 | 8.0 |
Netherlands | 13.5 | 1.9% | 8.1% | 2.71% | 1.78 | 5.5 |
Poland | 12.9 | 2.2% | 9.9% | 3.30% | 2.85 | 11.3 |
Serbia | 10.8 | 1.7% | 6.8% | 2.27% | 4.93 | 18.0 |
Germany | 12.8 | 2.4% | 9.1% | 3.04% | 2.71 | 8.9 |